Table 3.
Plasma PYY (ng/L), GIP (ng/L) and paracetamol (mg/L) concentrations following consumption of interesterified and non-interesterified fat blends (0–240 min)
| Time (min)a | Non-IE PSt/K | IE PSt/PK |
|---|---|---|
| GIP | ||
| 0 | 51 (20, 83) | 35 (26, 45) |
| 30 | 265 (212, 318) | 241 (186, 296) |
| 60 | 283 (212, 354) | 260 (207, 134) |
| 120 | 299 (246, 352) | 309 (243, 375) |
| 180 | 281 (208, 354) | 341 (245, 384) |
| 240 | 201 (160, 242) | 208 (155, 261) |
| PYY | ||
| 0 | 107 (92, 121) | 104 (81, 127) |
| 30 | 122 (110, 134) | 134 (110, 159) |
| 60 | 135 (123, 148) | 139 (113, 165) |
| 120 | 130 (114, 146) | 124 (105, 142) |
| 180 | 124 (112, 136) | 124 (110, 138) |
| 240 | 132 (121, 144) | 121 (112, 131) |
| Paracetamol | ||
| 0 | 0.0 (0.0, 0.0) | 0.0 (0.0, 0.0) |
| 30 | 3.8 (3.1, 4.6) | 4.3 (3.6, 5.1) |
| 60 | 7.0 (5.9, 8.1) | 6.8 (5.6, 7.9) |
| 120 | 9.8 (8.7, 10.8) | 9.7 (8.4, 11.0) |
| 180 | 8.1 (7.4, 8.8) | 7.8 (6.6, 8.9) |
| 240 | 5.9 (5.1, 6.7) | 5.9 (5.0, 6.9) |
Values are means with 95 % CI
aDeviations from fasting values were analysed by ANOVA, with meal type and time as within-subject factors. Time effect for all measures P < 0.001